http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018093331-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
filingDate 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a82107bd5534b682cc8c52042499188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bedf1a72d9240607126da398f9e6dab6
publicationDate 2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018093331-A1
titleOfInvention Attenuated glutamine synthetase as a selection marker
abstract The invention relates to an expression vector comprising a polynucleotide encoding a mutated glutamine synthetase (GS) with reduced activity, and the GS mutant is used as a selection marker in a method for producing a polypeptide of interest wherein the addition of GS inhibitor may not be required. Also disclosed the GS mutant comprising one or more mutations in the glutamate binding region, the ATP binding region and/or the ammonia binding region.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023180398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023180374-A1
priorityDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017197098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014133468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012301919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005106580-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008116931-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010147462-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94270

Total number of triples: 36.